University of Utah - Huntsman Cancer Institute — Salt Lake City, Utah

Public research footprint of University of Utah - Huntsman Cancer Institute, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Acute Myeloid Leukemia · Metastatic Hormone Receptor Positive Breast Cancer

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT06465069 — A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Utah - Huntsman Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.